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Abstract
Background: Intra-articular shift (migration) of bone marrow edema syndrome (BMES) is a very
rare disease. Only a few cases have been reported thus far. The condition may cause the clinician
to suspect an aggressive disease.
Methods: We reviewed eight patients (four women and four men) with unilateral BMES located
in the knee. The patients were aged 39 to 56 years (mean, 49.2 years). In all patients, bone marrow
edema (BME) initially observed on magnetic resonance imaging (MR imaging) shifted within the
same joint, i.e. from the medial to the lateral femoral condyle or the adjacent bone. Seven patients
were given conservative therapy, including limited weight-bearing, for a period of three weeks after
the initial detection of BMES, whereas one patient underwent surgical core decompression twice.
Results: MR imaging showed complete restitution in 6 cases and a small residual edema in one
case. A final control MR could not be obtained for one patient, who had no pain. A further patient
had an avascular necrosis of the contralateral hip after 16 months. Improvement on MR imaging
was correlated with the clinical outcome in all cases. All patients became asymptomatic after a
mean period of 9 months (6–11).
Interpretation: Intra-articular shifting BMES is a very rare condition. As the disease is self-limiting,
conservative therapy may be recommended.
Introduction
Bone marrow edema syndrome (BMES) is a common
cause of severe bone and joint pain. The disease is usually
self-limiting in nature and the symptoms resolve sponta-
neously over a period of 6, or occasionally 12 months.
BMES primarily occurs in the femoral head, but also in the
knee, foot, or less frequently at other locations. The
patients complain of pain under stress and at rest, as well
as a limited range of motion in the affected joint.
The exact pathogenesis of BMES remains unclear. Com-
monly discussed theories include thromboembolism,
obstruction of arteriolar inflow or venous outflow, injury
to the vessel wall secondary to vasculitis, altered lipid
metabolism, and reduced fibrinolysis [1-4].
Bone marrow edema (BME) shows reduced signal inten-
sity on T1-weighted MR images and increased signal
intensity on T2-weighted MR images. No focal changes are
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identified and joint effusion is usually present [5]. The
radiographs are initially normal but patients may subse-
quently develop severe osteopenia.
BMES is known to migrate between different joints of the
same limb or different limbs (migratory osteoporosis,
migrating BMES) [6]. However, to our knowledge, shift-
ing of BMES between different compartments of the same
joint has been previously reported only in a few cases [7-
11]. The purpose of this retrospective study was to analyze
the clinical course and MR images of this rare disease.
Methods
Eight patients (four women and four men) aged 39 to 56
years (mean, 49.2 years), with intra-articular migratory
BMES, were investigated retrospectively. The patients were
retrieved from a collective of 50 consecutively diagnosed
cases of painful BMES of the knee treated conservatively
and by surgery. On the routinely performed MR investiga-
tion three months after the initial diagnosis, the location
of the BME in the knee was found to have shifted to a dif-
ferent part of the knee. Patients with avascular necrosis
(AVN) in the knee and other joints, and osteochondritis
dissecans in a demarcated bone area; patients with BME
secondary to osteoarthritis, mechanical stress or trauma;
and patients with algodystrophy and corticosteroid medi-
cation at initial presentation were excluded. The average
duration of pain had been 10 weeks (range, 6 to 18
weeks). Six patients (two women and four men) per-
formed light sports (about 1 hour per week; one played
soccer, two played tennis and three played golf). No
patient presented with a history of BME in other joints
than the knee. One had undergone surgery (partial medial
meniscectomy) in the affected knee two years previously.
The laboratory data of the eight patients revealed mild
lipid disorders in three patients, hyperglycemia in two,
and elevated liver function tests in a further three patients
(see additional file 1). Apart from these, no major disor-
ders were found in blood parameters. Three patients
smoked (5–30 cigarettes/day) and three reported regular
intake of alcohol. The average body mass index (BMI) was
27.9 ± 7.3 (19.5 to 38.2); two patients were obese (BMI
33.8 and 38.2).
Plain anteroposterior and lateral radiographs under
weight-bearing were available for every patient. They were
found to be normal in five patients whereas two showed
mild radiographic signs of osteoporosis and one showed
minimal narrowing of the joint space in the bones
affected by BME. Two patients presented with a mild varus
deformity (hip/ankle angle 3° and 4° varus) of the leg
axis.
MR imaging, including T1-weighted and T2-weighted fat
suppressed (short tau inversion recovery) sequences, was
performed before therapy. MR imaging was repeated every
12 weeks (8–14 weeks) until the MR imaging pattern nor-
malized and the patients had no pain.
Treatment after the initial MR study consisted of a series
of five infusions with 20 µg iloprost (Ilomedin®, Schering
AG, Germany) in off-label use and in an inpatient proce-
dure in seven patients, accompanied by 3 weeks of partial
weight-bearing. Iloprost is a vasoactive prostacyclin ana-
logue which dilates arterioles and venules, reduces capil-
lary permeability and inhibits platelet aggregation [12].
One patient with BMES of the medial femoral condyle
underwent core decompression of the affected condyle.
Pain at rest and effort-induced pain were rated by the
patients at each visit on a visual analogue scale (VAS)
from 0 to 10 cm.
Findings
At baseline MR imaging, six patients had BME in the
medial femoral condyle, one patient in the lateral femoral
condyle, and one in the lateral tibial plateau. The size of
the BME was deemed large (50–100% of the femoral con-
dyle or the tibial plateau) in five cases and medium (25–
50%) in three cases. In addition, a mild effusion was
detected in five of the eight cases. At the first MR imaging
control performed 3 months after baseline, the BME had
shifted horizontally from the medial to the adjacent lat-
eral femoral condyle in three patients and vertically in two
patients (one from lateral tibial plateau to the medial fem-
oral condyle, and one vice versa). Two patients showed
migration to the neighboring femoral condyle and to the
lateral tibial plateau, one of these with an additional shift
to the medial tibial plateau. In one patient a shift from the
medial femoral condyle and the lateral as well as medial
tibial plateau was observed (see additional file 1 and fig-
ure 1). The newly affected quadrants were large in one
case, medium in five, and small in two cases. Healing of
the primarily affected quadrants was seen only in one
patient, partial regression in size in three patients, and no
change of the BME pattern in the remaining four. Five
patients stated that the location of the diffuse pain in the
knee had changed since the beginning of the disease.
The patients continued the conservative therapy accompa-
nied by reduction of their daily-life activities (seven
patients), partial weight-bearing (two patients for a fur-
ther 4 weeks), or intake of non-steroidal anti-phlogistic
drugs (six patients) after the intra-articular migration of
the BMES had been diagnosed. One patient with BMES in
the medial femoral condyle underwent core decompres-
sion of the medial femoral condyle after BMES had been
initially diagnosed; drilling of the lateral femoral condyle
was performed 5 months after the first operation.BMC Musculoskeletal Disorders 2008, 9:45 http://www.biomedcentral.com/1471-2474/9/45
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The final MR investigation performed on average 8
months after baseline (range, 7–11 months) showed full
resolution of BMES in 6 patients (figures 2 to 7). One
patient had small residual edematous bone areas. No
quadrant was newly affected. A final MR control could not
be performed in one patient, who was free of pain.
The severity of effort-induced pain (VAS) was reduced
from 7.5 (2.0–10.0) at baseline to 5.9 (2.4–7.9) after 3
months and to 0.6 (0–0.9) after the final examination.
Pain at rest (VAS) diminished from 3.9 (1.5–7.8) to 2.8
(1.4–6.0) after 3 months and to 0 at the final follow-up.
In one patient with BMES in the knee, avascular necrosis
of the contralateral hip was evident within 16 months,
which is being treated conservatively until the present
time. All active patients were able to return to the same
level of sports as that prior to commencement of their
symptoms.
Discussion
In 1959 Curtiss and Kincaid [13] reported three cases of
young women who developed transient demineralization
of the hip during the third trimester of pregnancy. Wilson
Shift of bone marrow edema Figure 1
Shift of bone marrow edema.
48-year-old man with a large BME in the medial femoral con- dyle not limited to the subchondral bone on the initial T2- weighted MR investigation (STIR) Figure 2
48-year-old man with a large BME in the medial fem-
oral condyle not limited to the subchondral bone on 
the initial T2-weighted MR investigation (STIR).
The MR investigation shows a shift of a large BME to the  medial and the lateral tibial plateau, and a reduction in the  size of the BME in the medial femoral condyle 3 months later Figure 3
The MR investigation shows a shift of a large BME to 
the medial and the lateral tibial plateau, and a reduc-
tion in the size of the BME in the medial femoral con-
dyle 3 months later.BMC Musculoskeletal Disorders 2008, 9:45 http://www.biomedcentral.com/1471-2474/9/45
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Complete normalization of the MRI signal pattern after 6  months of conservative treatment Figure 4
Complete normalization of the MRI signal pattern 
after 6 months of conservative treatment.
44-year-old woman with a extensive BME in the medial fem- oral condyle which is not limited to the subchondral area on  the T2-weighted MR investigation (STIR) Figure 5
44-year-old woman with a extensive BME in the 
medial femoral condyle which is not limited to the 
subchondral area on the T2-weighted MR investiga-
tion (STIR).
The MR image shows a shift of the large BME to the lateral  femoral condyle, reduction in the size of the BME in the  medial femoral condyle, and remission at the medial tibial  condyle 4 months later Figure 6
The MR image shows a shift of the large BME to the 
lateral femoral condyle, reduction in the size of the 
BME in the medial femoral condyle, and remission at 
the medial tibial condyle 4 months later.
Complete normalization of the MR imaging signal pattern  after 10 months Figure 7
Complete normalization of the MR imaging signal 
pattern after 10 months.BMC Musculoskeletal Disorders 2008, 9:45 http://www.biomedcentral.com/1471-2474/9/45
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e
t al. coined the term BME in 1988 after the introduction
of MR imaging. It is controversially discussed as to
whether BMES reflects a distinct self-limiting disease, a
kind of reflex sympathetic dystrophy, or an early reversi-
ble form of osteonecrosis [1,10,14-16]. However, avascu-
lar osteonecrosis and BME are known to occur in different
populations, which would militate against a common eti-
ology. On the other hand, one of our patients with BMES
in the knee showed avascular necrosis in the femoral
head, which indicates a relationship between the two enti-
ties.
BMES is usually associated with a spontaneous onset of
pain in the absence of prior trauma. Physical findings are
minimal and laboratory values are usually normal or non-
specific. Clinical improvement usually occurs over a
period of 6, or occasionally 12 months. Joints of the lower
limbs are much more commonly affected than those of
the upper limbs.
Therapy options are conservative treatment (reduction of
weight-bearing, analgesic and anti-inflammatory medica-
tion) and surgical treatment (core decompression) [17].
In our department we usually treat patients presenting
with BMES with intravenous iloprost in combination with
reduced weight-bearing, which appears to accelerate the
natural course of the disease in many cases [16,18-22].
Many patients experience recurrence of BME in other
joints, usually on the contralateral side. The term 'regional
migrating osteoporosis' or 'regional migrating BMES' has
been used in these cases. To our knowledge, a shift of BME
within the different compartments of the same joint has
only been described in a few case reports. As in our cases,
migratory BMES had a benign course and improvement
on the MR images was correlated with the clinical out-
come in all patients [7-11].
In studies focusing on the knees, BMES was initially
present in one femoral condyle and shifted to the contral-
ateral femoral condyle or the tibia within a period of 2 to
4 months. In theory, this condylar shift could be due to a
compensatory mechanism whereby the patient shifts
weight-bearing to the unaffected painless side of the knee.
However, this theory is rejected by some authors [9]. In a
further study, BME in healthy volunteers with altered
weight-bearing was less extensive in size and milder than
that observed in our cases [23]. In another study it was
found that typical BME caused by mechanical stress was
mild, and located in the subchondral area. It had a linear
or wedge-shaped appearance, whereas idiopathic BMES is
characterized by large areas being affected, and not being
limited to the subchondral bone [17]. Therefore, all three
cases of BME with minimal degenerative changes in the
joint and large edematous areas without limitation to the
subchondral region were considered to be of primarily
ischemic origin.
Finally, we observed normalization of the MR imaging
pattern in all patients treated with conservative therapy
alone, which would contradict a purely mechanical etiol-
ogy of the BMES. While the presence of meniscal tears
might lead to altered biomechanical loading, we do not
believe this is responsible for the shift of edema since this
kind of BME due to biomechanical stress would be lim-
ited to the subchondral bone. In addition, this situation
would more likely explain a vertical shift, for instance
from the medial femoral condyle to the medial tibial pla-
teau, rather than a horizontal migration from medial to
lateral.
Our patients did not show a subchondral linear abnormal
signal pattern of this type, but had a large BME affecting at
least 25% of the femoral condyle or the tibial plateau. Fur-
thermore, no association was found between the size of
BME and its migration. In those cases in which BME shifts
to an adjacent quadrant, it appears that the origin is the
primary affected quadrant. However, in cases of atypical
migration (such as from proximal to distal or vice versa or
diagonally), it is unclear whether the condition is a shift-
ing or a new BME. The authors' thesis of the pathogenesis
of intra-articular migratory BMES is a regional, diffuse,
and therefore reversible ischemia of unknown origin
affecting adjacent bones or parts of a bone. The non-
simultaneous but consecutive affliction prolongs the total
duration of pain than that seen in ordinary BMES. A pro-
gression to an AVN is not likely but cannot be entirely
ruled out, depending on the extent of damage to the ter-
minal vascular bed.
Intra-articular shifting (or migrating) BMES has also been
reported in other joints of the lower limb. Fernandez-Can-
ton [24] published 25 cases of BME in the foot with a one-
year follow-up. Six of seven cases without complete resti-
tution of the BME showed migration of BME to other
bones that were initially normal, or to previously non-
edematous areas of affected bones. Furthermore, the
authors noted soft tissue edema in all 25 cases of BME of
the foot, and joint effusion in 10 of 25 cases.
In addition, the diagnosis of BME migration may be sug-
gested only after other causes of edema, such as avascular
necrosis, subchondral insufficiency fracture, infection,
and post-traumatic bone bruise, have been excluded. We
continue to perform MR imaging studies every three
months in patients whose symptoms do not abate under
conservative therapy. Furthermore, we recommend early
MR imaging diagnosis of other painful joints such as theBMC Musculoskeletal Disorders 2008, 9:45 http://www.biomedcentral.com/1471-2474/9/45
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hip, knee and ankle, especially on the contralateral side,
to detect migrating BMES.
The vasoactive drug iloprost did not accelerate the course
of the disease in patients with intra-articular shifting
BMES as it does in non-shifting BMES [16,18-22] nor did
it prevent shifting within the joint. Nevertheless, we rec-
ommend conservative therapy with partial weight-bearing
and the administration of non-steroidal analgesic drugs
rather than core decompression in these cases.
Limitations of the present report are the small number of
patients and the retrospective nature of the study, which is
due to the fact that this entity is very rarely seen. Further
investigations are needed for a more comprehensive
understanding of this disease.
Conclusion
Intra-articular migration of a large BMES appears to be an
aggressive phenomenon, but the disease has a benign
course and is self-limiting in nature. We therefore recom-
mend conservative therapy.
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